Aner Ottolenghi
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 3
- SARS-CoV-2 detection and testing 3
- COVID-19 Clinical Research Studies 2
- Viral gastroenteritis research and epidemiology 1
-
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 2
-
- CAR-T cell therapy research 2
- Bone health and treatments 1
- Co-authors
- Angel PorgadorYariv GreenshpanBenjamin GeigerMati MannZvi KamNoam LevaotKiran KunduAvishay Edri
- Journals
- PLoS ONE (1 paper)Scientific Reports (2 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- IsraelUnited StatesMexico
In The Last Decade
Aner Ottolenghi
13 papers receiving 256 citations
Peers
Comparison fields: 5 of 71
- Infectious Diseases 119
- Immunology 51
- Oncology 62
- Modeling and Simulation 9
- Biomedical Engineering 69
Countries citing papers authored by Aner Ottolenghi
This map shows the geographic impact of Aner Ottolenghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aner Ottolenghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aner Ottolenghi more than expected).
Fields of papers citing papers by Aner Ottolenghi
This network shows the impact of papers produced by Aner Ottolenghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aner Ottolenghi. The network helps show where Aner Ottolenghi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aner Ottolenghi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 7 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 20 | |
| 8 | 2021 | 19 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 11 | |
| 11 | 2020 | 96 | |
| 12 | 2020 | 11 | |
| 13 | 2017 | 14 | |
| 14 | 2015 | 46 |
About Aner Ottolenghi
Aner Ottolenghi is a scholar working on Infectious Diseases, Immunology and Oncology, having authored 14 papers that have together received 257 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers), SARS-CoV-2 detection and testing (3 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), COVID-19 Clinical Research Studies (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and Bone health and treatments (1 paper). The work is most often cited by research in Infectious Diseases (119 citations), Immunology (51 citations) and Oncology (62 citations). Aner Ottolenghi has collaborated with scholars based in Israel, United States and Mexico. Frequent co-authors include Angel Porgador, Yariv Greenshpan, Benjamin Geiger, Mati Mann, Zvi Kam, Noam Levaot, Kiran Kundu, Avishay Edri, Lior Nesher and Lilach M. Friedman. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.